Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2003
11/20/2003WO2003095942A2 System and method for control of paint thickness by using an optoacoustic technique
11/20/2003WO2003095941A2 System and method for controlling tube thickness with ultrasound
11/20/2003WO2003095744A1 System and method for online control of paper elasticity and thickness
11/20/2003WO2003095678A1 Ldl receptor-related proteins 1 and 2 and treatment of bone or cartilage conditions
11/20/2003WO2003095674A2 Methods for evaluating a disease condition by detection of particle and non-particle bound nucleic acids in blood plasma and serum
11/20/2003WO2003095669A1 Stochastic sensing through covalent interactions
11/20/2003WO2003095668A1 Quality assays for antigen presenting cells
11/20/2003WO2003095667A2 Autoimmune conditions and nadph oxidase defects
11/20/2003WO2003095663A2 Modified t lymphocytes and uses therefor
11/20/2003WO2003095662A2 Simultaneous detection of two analytes produced by a cell under the influence of a putative agent using a pin coated assay system
11/20/2003WO2003095645A1 Assay for melanogenesis
11/20/2003WO2003095644A1 Novel proteins and dnas thereof
11/20/2003WO2003095624A2 Liver inflammation predictive genes
11/20/2003WO2003095620A2 Oocyte recording chamber
11/20/2003WO2003095619A2 Protein complex purification
11/20/2003WO2003095617A2 A method and apparatus for providing signal analysis of a bionems resonator or transducer
11/20/2003WO2003095616A2 Dynamics bionems sensors and arrays of bionems sensor immersed in fluids
11/20/2003WO2003095610A2 Directed evolution method of generating enhanced folding polypeptide variants
11/20/2003WO2003095607A2 Role of p62 in aging-related disease
11/20/2003WO2003095606A2 A t cell subpopulation regulating gut immunity
11/20/2003WO2003095605A2 A chimeric reverse transcriptase and methods for identifying telomerase inhibitors
11/20/2003WO2003095515A2 A method to rapidly prepare and screen formulations and compositions containing same
11/20/2003WO2003095481A1 Streptococcal superantigens spe-l and spe-m
11/20/2003WO2003095480A2 Brachyspira hyodysenteriae vaccine
11/20/2003WO2003095478A1 Thermostable and monoconjugatable gold cluster complexes
11/20/2003WO2003095477A2 Miniprotein ligands and other polypeptides and methods for making and using same
11/20/2003WO2003095475A2 Peptide compounds and their use as protease substrates
11/20/2003WO2003095457A1 Adenosine a3 receptor modulators
11/20/2003WO2003095196A1 Apparatus and method for high throughput analysis of compound-membrane interactions
11/20/2003WO2003095092A1 Sampling device for liquid samples
11/20/2003WO2003094965A2 Modulation of neural stem cells with s1p or lpa receptor agonists
11/20/2003WO2003094932A1 Carbon monoxide as a biomarker and therapeutic agent
11/20/2003WO2003094926A1 Fluorescent sensor compounds for detecting saccharides
11/20/2003WO2003094859A2 Epha2 monoclonal antibodies and methods of use thereof
11/20/2003WO2003094856A2 1l1rl-1 as a cardiovascular disease marker and therapeutic target
11/20/2003WO2003094844A2 Prostate cancer-related compositions, methods, and kits based on dna macroarray proteomics platforms
11/20/2003WO2003094838A2 Simple catalytic dna biosensors for ions based on color changes
11/20/2003WO2003094836A2 Methods and products for enhancing immune responses using imidazoquinoline compounds
11/20/2003WO2003094770A1 Whole blood sampling device
11/20/2003WO2003094752A1 Sampling module device and method
11/20/2003WO2003094714A1 Real time self-adjusting calibration algorithm
11/20/2003WO2003094712A2 System for point of care diagnosis and/or analysis
11/20/2003WO2003081996A3 Non-human transgenic mammals carrying germile mutations in both the p53 andfos genes and their use as a disease model
11/20/2003WO2003079401A3 Directed assembly of functional heterostructures
11/20/2003WO2003068979A3 System and methods for discriminating an agent
11/20/2003WO2003067253A3 Self-calibrating carbon monoxide detector and method
11/20/2003WO2003066849A3 Novel purified polypeptides from staphylococcus aureus
11/20/2003WO2003062827A3 Fluorescent detection of proteins in polyacrylamide gels
11/20/2003WO2003062783A3 Light addressable electrochemical detection of duplex structures
11/20/2003WO2003058251A3 Toxicity test
11/20/2003WO2003055915A3 Human netrin receptor and uses thereof
11/20/2003WO2003054525A3 Device and method for investigating analytes in liquid suspension or solution
11/20/2003WO2003054012A3 Leptin proteins
11/20/2003WO2003053581A3 Biomolecule handling method and machine using an array dispenser
11/20/2003WO2003052407A3 Analytical method and apparatus for analysis for surfactants in hydrocarbon distillate fuels
11/20/2003WO2003052070A3 Vps41s as modifiers of cell death and methods of use
11/20/2003WO2003050544A3 Methods for protein analysis using protein capture arrays
11/20/2003WO2003050504A3 Methods and compositions to treat cardiovascular disease usin g 1419, 58765 and 2201
11/20/2003WO2003050287A3 Method for modifying plant morphology, biochemistry and physiology comprising expression of plant cytokinin oxidase
11/20/2003WO2003050237A3 Triazine library with linkers
11/20/2003WO2003048768A3 Protein arrays for allelic variants and uses thereof
11/20/2003WO2003048734A3 Detection of matrix metalloproteinase rna in plasma and serum
11/20/2003WO2003045993A3 Protein biopolymer markers predictive of type ii diabetes
11/20/2003WO2003044172A3 Composition comprising and method of using angiopoietin-like protein 3 angptl3
11/20/2003WO2003042401A3 Novel chromophores/fluorophores and methods for using the same
11/20/2003WO2003042363A3 Eit-6, a polypeptide encoded by an estrogen regulated gene
11/20/2003WO2003042357A3 Enzymes
11/20/2003WO2003041830A3 Macroporous gel, its preparation and its use
11/20/2003WO2003040705A3 A manifold device comprising a plurality of flow cells and fiber-optic probes for dissolution systems, and method
11/20/2003WO2003040183A3 Compounds for the diagnosis/prevention/treatment of alzheimer's disease
11/20/2003WO2003038110A3 7118, a human arginine n-methyltransferase family member and uses therefor
11/20/2003WO2003036264A3 Treating diseases mediated by metalloprotease-shed proteins
11/20/2003WO2003034027A3 Whole cell assay
11/20/2003WO2003033529A3 Tr4, tr4 activators, tr4 inhibitors or tr4-associated molecules for treating leukaemic diseases
11/20/2003WO2003033009A3 Novel drug targets for arthritis
11/20/2003WO2003031567A3 Precursor conversion screening methods
11/20/2003WO2003030836A3 Neuronal regeneration
11/20/2003WO2003027634A3 Identification of modulatory molecules using inducible promoters
11/20/2003WO2003023573A3 Patient classification
11/20/2003WO2003022993A3 Methods for producing ex vivo models for inflammatory disease and uses thereof
11/20/2003WO2003022421A3 Microcolumn-platform based array for high-throughput analysis
11/20/2003WO2003021261A3 Methods for predicting drug sensitivity in patients afflicted with an inflammatory disease
11/20/2003WO2003021260A3 Method for gas chromatographic analysis of a urine sample
11/20/2003WO2003021253A3 Bioanalytical recognition surface with optimised recognition element density
11/20/2003WO2003020909A3 Methods for the identification of polypeptide antigens associated with disorders involving aberrant cell proliferation and compositions useful for the treatment of such disorders
11/20/2003WO2003019136A3 Methods for inhibiting angiogenesis
11/20/2003WO2003019135A3 Reference control for high-sensitivity c-reactive protein testing
11/20/2003WO2003016506A3 Secreted proteins
11/20/2003WO2003016344A3 Use of lung carcinoma antigen
11/20/2003WO2003012093A3 Regulator of calcineurin
11/20/2003WO2003010331A3 Immobilisation of proteins and electroactive compounds on a sensor surface by means of a hydrophobin coating
11/20/2003WO2003008972A3 Method for simultaneous multiple probes/multiple targets screening procedure
11/20/2003WO2003008638A3 Sorting and immobilization system for nucleic acids using synthetic bidning systems
11/20/2003WO2003007884A3 Method and reagents for identifying gene targets for treating breast cancer
11/20/2003WO2003006627A8 Leukemogenic transcription factors
11/20/2003WO2003006447A3 Interaction inhibitors of tcf-4 with beta-catenin
11/20/2003WO2003004627B1 Novel human hepatoma lines, methods for obtaining same and uses thereof
11/20/2003WO2003004613A3 Novel pgc-1 isoforms and uses therefor
11/20/2003WO2003000891A3 Protein-protein interactions in the inner ear
11/20/2003WO2003000864A3 Nucleic acid-associated proteins
1 ... 2459 2460 2461 2462 2463 2464 2465 2466 2467 2468 2469 2470 2471 2472 2473 2474 2475 2476 2477 2478 2479 ... 3937